The Efficacy and Safety of Modified Docetaxel, Cisplatin, and 5-Fluorouracil Vs. Epirubicin, Oxaliplatin, and Capecitabine Regimen in the Advanced Gastric Cancer: A Randomized Controlled Clinical Trial.

Ahmad AhmadzadehSeyed Saeid SeyedianArmita ValizadehMahin SoleimaniPedram NazariHossein Hamidi

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

It seems that both m-DCF and EOX regimens are similar in terms of survival and toxicity and are recommended as first-line treatment for advanced gastric cancer with respect to the patient's status.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
phase ii study
squamous cell carcinoma
case report
radiation therapy
oxidative stress
free survival
lymph node
metastatic breast cancer
metastatic colorectal cancer
phase iii
open label